BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15906703)

  • 21. [Neonatal screening for congenital metabolic disorders in Bavaria--assessment of current status and planned reorganization].
    Liebl B; Roscher AA
    Gesundheitswesen; 1998 Aug; 60 Suppl 1():S20-3. PubMed ID: 9816756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient advocacy in newborn screening: continuities and discontinuities.
    Paul DB
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):8-14. PubMed ID: 18200523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass newborn screening in Singapore.
    Joseph R
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():89-90. PubMed ID: 15906706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International developments in newborn screening quality assurance.
    Webster D;
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():43-5. PubMed ID: 15906692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The failure to diagnose inborn errors of metabolism in New Zealand: the case for expanded newborn screening.
    Wilson C; Kerruish NJ; Wilcken B; Wiltshire E; Webster D
    N Z Med J; 2007 Sep; 120(1262):U2727. PubMed ID: 17891215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality assurance program for neonatal screening of glucose-6-phosphate dehydrogenase deficiency.
    Chiang SH; Wu KF; Liu TT; Wu SJ; Hsiao KJ
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():130-4. PubMed ID: 15906716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. California's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry.
    Feuchtbaum L; Lorey F; Faulkner L; Sherwin J; Currier R; Bhandal A; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S261-9. PubMed ID: 16735252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded newborn screening by tandem mass spectrometry: the Massachusetts and New England experience.
    Marsden D
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():111-4. PubMed ID: 15906712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newborn screening in Australia and New Zealand.
    Webster D; ;
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():69-70. PubMed ID: 15906698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
    Didycz B; Lemańska D; Słuszniak A
    Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenylketonuria detected by the neonatal screening program in Thailand.
    Pangkanon S; Ratrisawadi V; Charoensiriwatana W; Techasena W; Boonpuan K; Srisomsap C; Svasti J
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():179-81. PubMed ID: 15906730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland--experience and development of a routine program for expanded newborn screening.
    Lund AM; Hougaard DM; Simonsen H; Andresen BS; Christensen M; Dunø M; Skogstrand K; Olsen RK; Jensen UG; Cohen A; Larsen N; Saugmann-Jensen P; Gregersen N; Brandt NJ; Christensen E; Skovby F; Nørgaard-Pedersen B
    Mol Genet Metab; 2012 Nov; 107(3):281-93. PubMed ID: 22795865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Generalized neonatal screening based on laboratory tests].
    Ardaillou R; Le Gall JY
    Bull Acad Natl Med; 2006 Nov; 190(8):1745-59. PubMed ID: 17650757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in neonatal screening for genetic diseases of metabolism].
    Popescu V; Zamfirescu A
    Pediatrie (Bucur); 1992; 41(3):25-35. PubMed ID: 1327230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple positive results during a neonatal screening program: a retrospective analysis of incidence, clinical implications and outcomes.
    Zaffanello M; Maffeis C; Zamboni G
    J Perinat Med; 2005; 33(3):246-51. PubMed ID: 15914349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for congenital hypothyroidism--a new era in Bangladesh.
    Hasan M; Nahar N; Ahmed A; Moslem F
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():162-4. PubMed ID: 15906726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience].
    Bozkowa K; Cabalska B; Radomyska B; Ołtarzewski M; Lenartowska I
    Med Wieku Rozwoj; 1999; 3(4):529-59. PubMed ID: 10910678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The call from the newborn screening laboratory: frustration in the afternoon.
    Rhead WJ; Irons M
    Pediatr Clin North Am; 2004 Jun; 51(3):803-18, xii. PubMed ID: 15157599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn PKU screening in Turkey: at present and organization for future.
    Ozalp I; Coşkun T; Tokatli A; Kalkanoğlu HS; Dursun A; Tokol S; Köksal G; Ozgüc M; Köse R
    Turk J Pediatr; 2001; 43(2):97-101. PubMed ID: 11432505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.